Lowenstein Sandler represented Linqto, while Seward & Kissel acted as legal counsel to BCSA in the transaction. The financial technology investment platform Linqto, Inc. announced its plans...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Coya Therapeutics in the transaction. Coya Therapeutics (NASDAQ: COYA), a clinical-stage biotechnology company, announced the sale of $26.5 million worth of stock in a...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Coya Therapeutics in the transaction. Coya Therapeutics, Inc. (Nasdaq: COYA), a clinical-stage biotechnology company developing proprietary therapies to enhance the function of regulatory...
You must be a Standard 1 Year member to access this content.
Lowenstein represented Coffee Holding Co, Inc. in the transaction. The U.S.-based wholesale coffee roaster and dealer Coffee Holding Co, Inc. announced its definitive merger and share exchange...
You must be a Standard 1 Year member to access this content.
Lowenstein represented ZyVersa Therapeutics in the transaction, while Alston & Bird advised Larkspur Health Acquisition Corp. Manatt, Phelps & Phillips advised A.G.P./Alliance Global Partners. ZyVersa Therapeutics,...
You must be a Standard 1 Year member to access this content.
